questionsmedicales.fr
Facteurs biologiques
Antigènes
Antigènes thymo-indépendants
Antigènes thymo-indépendants : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Marqueurs immunologiques
Lymphocytes B
Symptômes
5
Symptômes
Réponse immunitaire
Réponse humorale
Anticorps
Prévention
5
Système immunitaire
Nutrition
Traitements
5
Immunomodulateurs
Réponse immunitaire
Antihistaminiques
Corticostéroïdes
Complications
5
Maladies auto-immunes
Lymphocytes B
Choc anaphylactique
Allergies
Suivi médical
Complications
Facteurs de risque
5
Immunodépression
Facteurs de risque
Antécédents familiaux
Allergies
Maladies chroniques
Facteurs de risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Antigènes thymo-indépendants : Questions médicales les plus fréquentes",
"headline": "Antigènes thymo-indépendants : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Antigènes thymo-indépendants : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-04",
"dateModified": "2026-01-24",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Antigènes thymo-indépendants"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Antigènes",
"url": "https://questionsmedicales.fr/mesh/D000941",
"about": {
"@type": "MedicalCondition",
"name": "Antigènes",
"code": {
"@type": "MedicalCode",
"code": "D000941",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.050"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Antigènes thymo-indépendants",
"alternateName": "Antigens, T-Independent",
"code": {
"@type": "MedicalCode",
"code": "D000955",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Shannon L Maude",
"url": "https://questionsmedicales.fr/author/Shannon%20L%20Maude",
"affiliation": {
"@type": "Organization",
"name": "Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA."
}
},
{
"@type": "Person",
"name": "Saar Gill",
"url": "https://questionsmedicales.fr/author/Saar%20Gill",
"affiliation": {
"@type": "Organization",
"name": "Division of Hematology and Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA."
}
},
{
"@type": "Person",
"name": "Alok V Joglekar",
"url": "https://questionsmedicales.fr/author/Alok%20V%20Joglekar",
"affiliation": {
"@type": "Organization",
"name": "Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. joglekar@pitt.edu."
}
},
{
"@type": "Person",
"name": "Guideng Li",
"url": "https://questionsmedicales.fr/author/Guideng%20Li",
"affiliation": {
"@type": "Organization",
"name": "Center of Systems Medicine, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. guidengl_ism@163.com."
}
},
{
"@type": "Person",
"name": "Noémie Paillon",
"url": "https://questionsmedicales.fr/author/No%C3%A9mie%20Paillon",
"affiliation": {
"@type": "Organization",
"name": "Institute Curie, Université PSL, U932 INSERM, Integrative Analysis of T cell Activation Team, Paris, France."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "GO-Tibia: a masked, randomized control trial evaluating gentamicin versus saline in open tibia fractures.",
"datePublished": "2023-06-15",
"url": "https://questionsmedicales.fr/article/37322521",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13063-023-07410-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Intra-articular proximal tibia fractures].",
"datePublished": "2023-08-08",
"url": "https://questionsmedicales.fr/article/37552247",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00113-023-01352-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "Geometric variation of the human tibia-fibula: a public dataset of tibia-fibula surface meshes and statistical shape model.",
"datePublished": "2023-02-16",
"url": "https://questionsmedicales.fr/article/36811007",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7717/peerj.14708"
}
},
{
"@type": "ScholarlyArticle",
"name": "Proximal tibia triplane fracture with apophyseal avulsion.",
"datePublished": "2023-07-25",
"url": "https://questionsmedicales.fr/article/37491124",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bcr-2022-254042"
}
},
{
"@type": "ScholarlyArticle",
"name": "Epidemiology of Physeal Fractures and Clinically Significant Growth Disturbances Affecting the Distal Tibia, Proximal Tibia, and Distal Femur: A Retrospective Cohort Study.",
"datePublished": "2023-04-12",
"url": "https://questionsmedicales.fr/article/37054395",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.5435/JAAOS-D-22-00303"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Facteurs biologiques",
"item": "https://questionsmedicales.fr/mesh/D001685"
},
{
"@type": "ListItem",
"position": 3,
"name": "Antigènes",
"item": "https://questionsmedicales.fr/mesh/D000941"
},
{
"@type": "ListItem",
"position": 4,
"name": "Antigènes thymo-indépendants",
"item": "https://questionsmedicales.fr/mesh/D000955"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Antigènes thymo-indépendants - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Antigènes thymo-indépendants",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-02-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Antigènes thymo-indépendants",
"description": "Comment identifier un antigène thymo-indépendant ?\nQuels tests sont utilisés pour évaluer la réponse immunitaire ?\nLes antigènes thymo-indépendants sont-ils visibles sur des biopsies ?\nPeut-on mesurer les niveaux d'anticorps spécifiques ?\nQuels marqueurs immunologiques sont associés ?",
"url": "https://questionsmedicales.fr/mesh/D000955?mesh_terms=Tibia#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Antigènes thymo-indépendants",
"description": "Quels symptômes indiquent une réponse immunitaire ?\nLes antigènes thymo-indépendants causent-ils des allergies ?\nY a-t-il des signes d'infection associés ?\nComment se manifeste une réponse humorale ?\nLes symptômes varient-ils selon l'antigène ?",
"url": "https://questionsmedicales.fr/mesh/D000955?mesh_terms=Tibia#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Antigènes thymo-indépendants",
"description": "Comment prévenir les infections liées aux antigènes ?\nLes mesures d'hygiène sont-elles efficaces ?\nFaut-il éviter certains aliments ?\nLes vaccinations sont-elles recommandées ?\nComment renforcer le système immunitaire ?",
"url": "https://questionsmedicales.fr/mesh/D000955?mesh_terms=Tibia#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Antigènes thymo-indépendants",
"description": "Quels traitements sont disponibles pour les infections ?\nPeut-on utiliser des immunomodulateurs ?\nLes vaccins sont-ils efficaces contre ces antigènes ?\nComment traiter les réactions allergiques ?\nY a-t-il des traitements préventifs ?",
"url": "https://questionsmedicales.fr/mesh/D000955?mesh_terms=Tibia#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Antigènes thymo-indépendants",
"description": "Quelles complications peuvent survenir ?\nLes antigènes peuvent-ils causer des maladies auto-immunes ?\nY a-t-il des risques de choc anaphylactique ?\nComment gérer les complications immunitaires ?\nLes complications sont-elles fréquentes ?",
"url": "https://questionsmedicales.fr/mesh/D000955?mesh_terms=Tibia#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Antigènes thymo-indépendants",
"description": "Quels facteurs augmentent le risque d'infection ?\nL'âge influence-t-il la réponse immunitaire ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe mode de vie affecte-t-il l'immunité ?\nLes maladies chroniques sont-elles un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D000955?mesh_terms=Tibia#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment identifier un antigène thymo-indépendant ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests immunologiques comme l'ELISA peuvent détecter ces antigènes."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer la réponse immunitaire ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests de prolifération des lymphocytes B et les dosages d'anticorps sont courants."
}
},
{
"@type": "Question",
"name": "Les antigènes thymo-indépendants sont-ils visibles sur des biopsies ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, ils ne sont pas directement visibles, mais leur effet peut être évalué par des tests."
}
},
{
"@type": "Question",
"name": "Peut-on mesurer les niveaux d'anticorps spécifiques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests sérologiques peuvent mesurer les anticorps contre ces antigènes."
}
},
{
"@type": "Question",
"name": "Quels marqueurs immunologiques sont associés ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les marqueurs comme CD19 et CD20 sont souvent utilisés pour évaluer les lymphocytes B."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une réponse immunitaire ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la fièvre, la fatigue et des douleurs peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les antigènes thymo-indépendants causent-ils des allergies ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent provoquer des réactions allergiques, mais ce n'est pas systématique."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes d'infection associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des signes comme rougeurs ou gonflements peuvent indiquer une infection."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une réponse humorale ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une augmentation des anticorps spécifiques dans le sang est un signe clé."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'antigène ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de l'antigène et de l'individu."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections liées aux antigènes ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir une bonne hygiène et se faire vacciner sont des mesures clés."
}
},
{
"@type": "Question",
"name": "Les mesures d'hygiène sont-elles efficaces ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le lavage des mains et la désinfection réduisent le risque d'infection."
}
},
{
"@type": "Question",
"name": "Faut-il éviter certains aliments ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les aliments allergènes peut prévenir des réactions indésirables."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles recommandées ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccinations peuvent prévenir certaines infections associées aux antigènes."
}
},
{
"@type": "Question",
"name": "Comment renforcer le système immunitaire ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée, l'exercice et le sommeil adéquat aident à renforcer l'immunité."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les infections ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antibiotiques et les antiviraux sont souvent utilisés selon l'infection."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser des immunomodulateurs ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des immunomodulateurs peuvent aider à réguler la réponse immunitaire."
}
},
{
"@type": "Question",
"name": "Les vaccins sont-ils efficaces contre ces antigènes ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains vaccins ciblent des antigènes thymo-indépendants pour renforcer l'immunité."
}
},
{
"@type": "Question",
"name": "Comment traiter les réactions allergiques ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antihistaminiques et les corticostéroïdes sont souvent prescrits."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements préventifs ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des vaccins et des traitements prophylactiques peuvent réduire les risques d'infection."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des infections récurrentes et des allergies sévères peuvent être des complications."
}
},
{
"@type": "Question",
"name": "Les antigènes peuvent-ils causer des maladies auto-immunes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une activation inappropriée des lymphocytes B peut mener à des maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de choc anaphylactique ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des réactions allergiques sévères peuvent entraîner un choc anaphylactique."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications immunitaires ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier et des traitements appropriés sont essentiels."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles varient selon l'individu et le type d'antigène, mais peuvent être sérieuses."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'infection ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'immunodépression, le stress et une mauvaise hygiène augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il la réponse immunitaire ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes enfants et les personnes âgées ont une réponse immunitaire plus faible."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents d'allergies ou de maladies auto-immunes augmentent le risque."
}
},
{
"@type": "Question",
"name": "Le mode de vie affecte-t-il l'immunité ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme, l'alcool et le manque d'exercice peuvent affaiblir l'immunité."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques sont-elles un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme le diabète ou l'asthme peuvent augmenter le risque d'infection."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 24/01/2026
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Publications dans "Antigènes thymo-indépendants" :
3 publications dans cette catégorie
Affiliations :
Division of Hematology and Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Publications dans "Antigènes thymo-indépendants" :
3 publications dans cette catégorie
Affiliations :
Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. joglekar@pitt.edu.
Center for Systems Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. joglekar@pitt.edu.
Department of Computational and Systems Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. joglekar@pitt.edu.
Publications dans "Antigènes thymo-indépendants" :
3 publications dans cette catégorie
Affiliations :
Center of Systems Medicine, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. guidengl_ism@163.com.
Suzhou Institute of Systems Medicine, Suzhou, China. guidengl_ism@163.com.
Key Laboratory of Synthetic Biology Regulatory Element, Chinese Academy of Medical Sciences, Beijing, China. guidengl_ism@163.com.
Publications dans "Antigènes thymo-indépendants" :
2 publications dans cette catégorie
Affiliations :
Institute Curie, Université PSL, U932 INSERM, Integrative Analysis of T cell Activation Team, Paris, France.
Publications dans "Antigènes thymo-indépendants" :
2 publications dans cette catégorie
Affiliations :
Institute Curie, Université PSL, U932 INSERM, Integrative Analysis of T cell Activation Team, Paris, France.
Publications dans "Antigènes thymo-indépendants" :
2 publications dans cette catégorie
Affiliations :
Apitope International NV, Diepenbeek, Belgium.
Publications dans "Antigènes thymo-indépendants" :
2 publications dans cette catégorie
Affiliations :
Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
Publications dans "Antigènes thymo-indépendants" :
2 publications dans cette catégorie
Affiliations :
Division of Hematology and Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. nathan.singh@wustl.edu.
Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. nathan.singh@wustl.edu.
Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA. nathan.singh@wustl.edu.
Publications dans "Antigènes thymo-indépendants" :
2 publications dans cette catégorie
Affiliations :
Division of Hematology and Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Publications dans "Antigènes thymo-indépendants" :
2 publications dans cette catégorie
Affiliations :
Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Publications dans "Antigènes thymo-indépendants" :
2 publications dans cette catégorie
Affiliations :
Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Publications dans "Antigènes thymo-indépendants" :
2 publications dans cette catégorie
Affiliations :
Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Publications dans "Antigènes thymo-indépendants" :
2 publications dans cette catégorie
Affiliations :
Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Publications dans "Antigènes thymo-indépendants" :
2 publications dans cette catégorie
Affiliations :
Penn Institute for Biomedical Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Publications dans "Antigènes thymo-indépendants" :
2 publications dans cette catégorie
Affiliations :
Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Publications dans "Antigènes thymo-indépendants" :
2 publications dans cette catégorie
Affiliations :
Division of Hematology and Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Publications dans "Antigènes thymo-indépendants" :
2 publications dans cette catégorie
Affiliations :
Division of Hematology and Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. mruella@upenn.edu.
Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. mruella@upenn.edu.
Publications dans "Antigènes thymo-indépendants" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Animal Tumor Models, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China.
Publications dans "Antigènes thymo-indépendants" :
2 publications dans cette catégorie
Affiliations :
Department of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.
Publications dans "Antigènes thymo-indépendants" :
The rate of open tibia fractures is rapidly increasing across the globe due to a recent rise in road traffic accidents, predominantly in low- and low-middle-income countries. These injuries are orthop...
This is a prospective randomized, masked, placebo-controlled superiority trial designed to evaluate the efficacy of locally administered gentamicin versus placebo in the prevention of fracture-related...
This study will definitively assess the effectiveness of local gentamicin for the prevention of fracture-related infections in adults with open tibia fractures in Tanzania. The results of this study h...
Clinicaltrials.gov NCT05157126. Registered on December 14, 2021....
The incidence of proximal intra-articular tibial fractures is continuously increasing. In addition to high-energy trauma in young patients, osteoporotic fractures occur more frequently in geriatric pa...
Variation in tibia geometry is a risk factor for tibial stress fractures. Geometric variability in bones is often quantified using statistical shape modelling. Statistical shape models (SSM) offer a m...
Lower limb computed tomography (CT) scans from the right tibia-fibula of 30 cadavers (male...
Overall size was the main source of variation in all three models accounting for 90.31%, 84.24% and 85.06%. Other sources of geometric variation in the tibia surface models included overall and midsha...
Variations that could increase the risk of tibial stress injury were observed, these included general tibial thickness, midshaft thickness, tibial length and medulla cavity diameter (indicative of cor...
Tibial tuberosity fractures occur in fewer than 1% of all paediatric fractures. We present this unusual case of an early adolescent football player who presented to the emergency department after sust...
Childhood fractures involving the physis potentially result in premature physeal closure that can lead to growth disturbances. Growth disturbances are challenging to treat with associated complication...
Data were retrospectively collected from patients undergoing fracture treatment at a level I pediatric trauma center between 2008 and 2018. The study was limited to patients 0.5 to 18.9 years with a t...
A total of 1,585 patients met the inclusion criteria. The incidence of CSGD was 5.0% (95% confidence interval, 3.8% to 6.6%). All cases of growth disturbance occurred within 2 years of initial injury....
All CSGDs occurred within 2 years of injury, indicating that these injuries should be followed for a period of at least 2 years. Patients with distal femoral or proximal tibial physeal fractures that ...
Level III Retrospective Cohort Study....
SummaryGiant cell tumours of bone are benign and locally aggressive tumours that usually occur in young adults and at the epiphysial locations after physeal closure. Occurrence outside of epiphysial l...
A 28-year-old man presented for a painful lower extremity mass. Imaging revealed a nonspecific, poorly defined lucent lesion in the left distal tibial cortex with scalloping. The diagnosis of intracor...
An intracortical schwannoma is a rare, benign lesion which may have atypical radiological findings and nonspecific presentations. Definitive diagnosis is made with permanent histology and S-100 immuno...
To determine the ideal entry point and direction of retrograde intramedullary nailing of the tibia....
The imaging data of patients with distal tibial fractures from June 2020 to December 2021 in our hospital were collected, and computer-aided design was performed. The relevant data were imported into ...
The ideal entry point of the retrograde intramedullary nailing was located at the midpoint of the medial malleolus in the C-arm fluoroscopic anteroposterior (AP) and lateral view. The ideal nail entry...
The ideal point and direction of nail insertion for retrograde tibial intramedullary nailing is a "double midpoint, double axis" approach....
Osteomyelitis is a bone inflammation that can be related to various infectious agents. As with any other type of inflammation, the prevailing symptoms and signs may include redness, swelling, pain, an...
A non-human immunodeficiency virus immunocompromised Greek female patient, 82 years old, visited the emergency department due to a 3 day pain located mainly over the left tibia's anterior surface, acc...
To our knowledge, this is the ninth cryptococcal osteomyelitis of the tibia to be recorded since 1974, and the most unusual finding was the bifocal nature of the infection, affecting both the tibia an...
To report the outcomes of patients with a fracture of the distal tibia who were treated with intramedullary nail versus locking plate in the five years after participating in the Fixation of Distal Ti...
The FixDT trial reported the results for 321 patients randomized to nail or locking plate fixation in the first 12 months after their injury. In this follow-up study, we report the results of 170 of t...
There was no evidence of a difference in patient-reported disability, health-related quality of life, or the need for further surgery between participants treated with either type of fixation at five ...
This study shows that the moderate levels of disability and reduced quality of life reported by participants 12 months after a fracture of the distal tibia persist in the medium term, with little evid...